Tag:

Mosquirix

Latest Headlines

Latest Headlines

Glaxo's malaria vaccine gets EMA green light

July 24, 2015 | By
GlaxoSmithKline's malaria vaccine, RTS,S or Mosquirix, has won a positive opinion from the EMA's Committee for Medicinal Products for Human Use for use in children aged 6 weeks to 17 months outside the European Union, the agency said in a statement.

GSK malaria vaccine works in major Phase III trial

October 20, 2011 | By
In a late-stage trial of 6,000 children, three doses of GlaxoSmithKline's malaria vaccine RTS,S (also known as Mosquirix) cut the risk of children contracting malaria in a follow-up conducted
Related Tags
Press Releases
  • Philips Volcano announces more than 5,000 Coronary Artery Disease patients enrolled in iFR Outcomes Trials
  • Sun Pharma enters Japanese prescription market
  • Veracyte Secures Up to $45 Million in Financing from Visium Healthcare Partners
  • Merck Statement on hep C verdict
  • Quanterix Raises $46 Million in Series D Financing
  • More Press Releases
Sponsored Links